PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28367059-0	2017	Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.	Niclosamide	0-11	signal transducer and activator of transcription 3	Homo sapiens	26-31	
28367059-2	2017	In this study, we show that niclosamide can potentially inhibit signal transducer and activator of transcription 3 (STAT3) in colon cancer cell lines.	Niclosamide	28-39	signal transducer and activator of transcription 3	Homo sapiens	64-114	
28367059-2	2017	In this study, we show that niclosamide can potentially inhibit signal transducer and activator of transcription 3 (STAT3) in colon cancer cell lines.	Niclosamide	28-39	signal transducer and activator of transcription 3	Homo sapiens	116-121	
28367059-3	2017	Combined inhibition of epidermal growth factor receptor and STAT3 by erlotinib and niclosamide synergistically induces apoptosis and antiproliferation in colon cancer cell lines.	Niclosamide	83-94	signal transducer and activator of transcription 3	Homo sapiens	60-65